A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Incyte Corporation
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
Eli Lilly and Company
Masonic Cancer Center, University of Minnesota
Altor BioScience
Dartmouth-Hitchcock Medical Center